An engaging discussion on how integrated care models are helping simplify specialty medication access and improve the experience for both patients and care teams.
The Future of Integrated Care: Redefining Specialty Medication Access and Affordability was originally released on April 1, 2026.
An accomplished executive healthcare leader with over 15 years of experience in the industry, Miranda began her career as a registered nurse in hematology and oncology and quickly advanced to leadership roles. While serving as the Associate Director of Emergency Services at The Ohio State University Comprehensive Cancer Center, she and her team successfully launched the first fully integrated oncology emergency department in the United States. Since joining CoverMyMeds in 2017, she has successfully built and led high-performing clinical, operational and product teams. As the Vice President of Specialty Product, she has responsibility for improving the medication access journey for patients on specialty medications. Miranda holds a Doctor of Nursing Practice and is involved in a number of community and professional organizations including the Ronald McDonald House of Central Ohio, Nationwide Children’s Hospital Foundation, and Pelotonia.
Molly Brady is a healthcare and technology leader with more than two decades of experience spanning oncology nursing, clinical operations, product management, and customer success. As Director of Customer Success at Ontada, a McKesson company, she leads strategic initiatives that elevate the customer experience, strengthen operational excellence, and advance patient centered care across community oncology. With expertise in EHR technology, including best-in-class AI capabilities, workflow optimization, and large scale practice adoption, Molly oversees a high performing team of Customer Success Account Managers and partners closely with cross functional teams—including Product, Design, Engineering, Clinical, and Leadership—to drive measurable outcomes for both US Oncology Network and Open Market practices. She has supported more than 120 oncology practices nationwide and directly manages complex, strategic accounts such as Texas Oncology. Throughout her career at McKesson and Ontada, Molly has played a pivotal role in implementing major technology solutions, including iKnowMed Generation 2, Clear Value Plus, Practice Insights, Ontada Health, and Lynx. Prior to her technology leadership roles, Molly served for more than a decade as an oncology nurse and clinical manager, where she led clinical teams, implemented new EHR systems, trained end users, and contributed to numerous quality improvement initiatives. Her clinical foundation informs her empathetic, customer focused approach and her dedication to improving care delivery in every setting. Molly earned a Bachelor of Science in Nursing and held ONS and ONCC certifications. She is based in Omaha, Nebraska.
An accomplished executive healthcare leader with over 15 years of experience in the industry, Miranda began her career as a registered nurse in hematology and oncology and quickly advanced to leadership roles. While serving as the Associate Director of Emergency Services at The Ohio State University Comprehensive Cancer Center, she and her team successfully launched the first fully integrated oncology emergency department in the United States. Since joining CoverMyMeds in 2017, she has successfully built and led high-performing clinical, operational and product teams. As the Vice President of Specialty Product, she has responsibility for improving the medication access journey for patients on specialty medications. Miranda holds a Doctor of Nursing Practice and is involved in a number of community and professional organizations including the Ronald McDonald House of Central Ohio, Nationwide Children’s Hospital Foundation, and Pelotonia.
Molly Brady is a healthcare and technology leader with more than two decades of experience spanning oncology nursing, clinical operations, product management, and customer success. As Director of Customer Success at Ontada, a McKesson company, she leads strategic initiatives that elevate the customer experience, strengthen operational excellence, and advance patient centered care across community oncology. With expertise in EHR technology, including best-in-class AI capabilities, workflow optimization, and large scale practice adoption, Molly oversees a high performing team of Customer Success Account Managers and partners closely with cross functional teams—including Product, Design, Engineering, Clinical, and Leadership—to drive measurable outcomes for both US Oncology Network and Open Market practices. She has supported more than 120 oncology practices nationwide and directly manages complex, strategic accounts such as Texas Oncology. Throughout her career at McKesson and Ontada, Molly has played a pivotal role in implementing major technology solutions, including iKnowMed Generation 2, Clear Value Plus, Practice Insights, Ontada Health, and Lynx. Prior to her technology leadership roles, Molly served for more than a decade as an oncology nurse and clinical manager, where she led clinical teams, implemented new EHR systems, trained end users, and contributed to numerous quality improvement initiatives. Her clinical foundation informs her empathetic, customer focused approach and her dedication to improving care delivery in every setting. Molly earned a Bachelor of Science in Nursing and held ONS and ONCC certifications. She is based in Omaha, Nebraska.
Starting specialty therapy can involve navigating as many as nine separate platforms. Watch this webinar to see how integrated solutions are simplifying access and reducing delays. In this webinar you’ll learn:
